Dentsply SironaXRAY
About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).
Employees: 15,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
86% more call options, than puts
Call options by funds: $5.35M | Put options by funds: $2.88M
0% more funds holding in top 10
Funds holding in top 10: 3 [Q1] → 3 (+0) [Q2]
0.57% less ownership
Funds ownership: 102.61% [Q1] → 102.04% (-0.57%) [Q2]
14% less funds holding
Funds holding: 436 [Q1] → 373 (-63) [Q2]
15% less repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 151
25% less capital invested
Capital invested by funds: $7.06B [Q1] → $5.28B (-$1.79B) [Q2]
56% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 112
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Evercore ISI Group Elizabeth Anderson 40% 1-year accuracy 10 / 25 met price target | 11%upside $27 | Outperform Maintained | 8 Oct 2024 |
Barrington Research Michael Petusky 46% 1-year accuracy 26 / 56 met price target | 48%upside $36 | Outperform Maintained | 20 Sept 2024 |
Needham David Saxon 31% 1-year accuracy 17 / 54 met price target | 39%upside $34 | Buy Reiterated | 20 Aug 2024 |
Needham David Saxon 31% 1-year accuracy 17 / 54 met price target | 39%upside $34 | Buy Maintained | 31 Jul 2024 |
Baird Jeffrey Johnson 0 / 0 met price target | 27%upside $31 | Neutral Maintained | 22 Jul 2024 |
Financial journalist opinion
Based on 3 articles about XRAY published over the past 30 days